[go: up one dir, main page]

UA80802C2 - Low hygroscopic aripiprazole drug substance and process for the preparation thereof - Google Patents

Low hygroscopic aripiprazole drug substance and process for the preparation thereof

Info

Publication number
UA80802C2
UA80802C2 UA2003010503A UA2003010503A UA80802C2 UA 80802 C2 UA80802 C2 UA 80802C2 UA 2003010503 A UA2003010503 A UA 2003010503A UA 2003010503 A UA2003010503 A UA 2003010503A UA 80802 C2 UA80802 C2 UA 80802C2
Authority
UA
Ukraine
Prior art keywords
preparation
low hygroscopic
drug substance
aripiprazole drug
hygroscopic aripiprazole
Prior art date
Application number
UA2003010503A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35846848&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA80802(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from CA 2379005 external-priority patent/CA2379005A1/en
Application filed filed Critical
Priority claimed from PCT/JP2002/009858 external-priority patent/WO2003026659A1/en
Publication of UA80802C2 publication Critical patent/UA80802C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention provides low hygroscopic forms of aripiprazole and processes for the preparation thereof which will not convert to a hydrate or lose their original solubility even when a medicinal preparation containing the aripiprazole anhydride crystals is stored for an extended period.
UA2003010503A 2001-09-25 2002-09-25 Low hygroscopic aripiprazole drug substance and process for the preparation thereof UA80802C2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001290645 2001-09-25
CA 2379005 CA2379005A1 (en) 2001-09-25 2002-03-27 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
PCT/JP2002/009858 WO2003026659A1 (en) 2001-09-25 2002-09-25 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof

Publications (1)

Publication Number Publication Date
UA80802C2 true UA80802C2 (en) 2007-11-12

Family

ID=35846848

Family Applications (1)

Application Number Title Priority Date Filing Date
UA2003010503A UA80802C2 (en) 2001-09-25 2002-09-25 Low hygroscopic aripiprazole drug substance and process for the preparation thereof

Country Status (2)

Country Link
RU (1) RU2259366C2 (en)
UA (1) UA80802C2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0500683A3 (en) * 2005-07-14 2009-03-30 Egis Gyogyszergyar Nyilvanosan New arylpiprazole salts for producing pharmaceutical composition
JPWO2011030575A1 (en) * 2009-09-11 2013-02-04 大塚製薬株式会社 Chronic pain treatment

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6327424A (en) * 1986-07-17 1988-02-05 Shionogi & Co Ltd Sustained release pharmaceutical and production thereof
US4803203A (en) * 1986-11-05 1989-02-07 Warner-Lambert Company Phenyl and heterocyclic piperazinyl alkoxy-benzheterocyclic compounds as antipsychotic agents
US5006528A (en) * 1988-10-31 1991-04-09 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives

Also Published As

Publication number Publication date
RU2259366C2 (en) 2005-08-27

Similar Documents

Publication Publication Date Title
PL360900A1 (en) Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
NZ504017A (en) Preparation of gatifloxacin and disodium edetate
MXPA02011425A (en) Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors.
HUP0303128A3 (en) Novel succinate salt of o-desmethyl-venlafaxine, process for preparation thereof, its use and pharmaceutical composition containing it
NO2005025I1 (en) Crystalline ceftiofur free acid, process for its preparation, and pharmaceutical composition
WO2003000695A8 (en) Pyrrolopyrimidines as protein kinase inhibitors
IL141157A0 (en) Salt form of pantoprazole and pharmaceutical compositions containing the same
AP2003002929A0 (en) Pyrrolopyrimidines as protein kinase inhibitors
MXPA03010549A (en) Oxcarbazepine dosage forms.
TR200102811T2 (en) Pharmaceutical preparation containing tolpersion for oral administration.
MXPA03010365A (en) The citrate salt of 5, 8, 14-triazatetracyclo(10.3.1.02.
PH12014500782A1 (en) Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
TR200101163T2 (en) Bile water substituted phenyl-alkenoylguanidines, production methods, uses
UA80802C2 (en) Low hygroscopic aripiprazole drug substance and process for the preparation thereof
ATE111734T1 (en) PROCESS FOR THE MANUFACTURE OF DIRECT-COMPRESSED TABLETS CONTAINING CEPHALOSPORANIC ACID DERIVATIVES.
MXPA03008837A (en) A stable pharmaceutical composition of pravastatin.
DE60019157D1 (en) METHOD OF PREPARING ARYLETHANOLAMINE DERIVATIVES FOR THE TREATMENT OF DIABETES AND FATIBILITY
GEP20053457B (en) Low Hygroscopic Aripiprazole Drug Substance and Processes for Preparation Thereof
PL368040A1 (en) Substituted 4-aminocyclohexanol derivatives
HUP0400925A3 (en) Azolycarbynol derivatives of aryl (or heteroaryl) for producing pharmaceutical compositions for the treatment of respiratory diseases
MY138319A (en) 1,5-benzodiazepine derivatives
EP1316547A4 (en) Novel crystals of n-hydroxy-2(s)-methyl-5-ethoxymethoxy -4(s)- n-(4-phenoxyphenylcarbonyl)amino]pentanamide, process for their production and medicines containing the crystals as the active ingredient
BG103923A (en) Sulphate salt of hiv protease inhibitor with improved peroral absorption and biopresence
HUP0203593A2 (en) Amycomycin, a process for its production and its use as a pharmaceutical
MY134931A (en) Oral galantamine solution